Glucagon and GLP-1 inhibit food intake and increase c-fos expression in similar appetite regulating centres in the brainstem and amygdala

International Journal of Obesity

Volumn 37, Issue 10, 2013, Pages 1391-1398

  Parker, J A ^a   McCullough, K A ^a   Field, B C T ^a   Minnion, J S ^a   Martin, N M ^a   Ghatei, M A ^a   Bloom, S R ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

amygdala; appetite; brainstem; food intake; GLP 1; Glucagon

Indexed keywords

GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; PROTEIN C FOS;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; APPETITE; AREA POSTREMA; ARTICLE; BRAIN STEM; CELL ACTIVATION; CONTROLLED STUDY; ENERGY EXPENDITURE; FEEDING; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NERVE CELL; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

MUS;

AMYGDALA; ANIMALS; APPETITE; BRAIN STEM; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; ENERGY METABOLISM; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; INJECTIONS, INTRAPERITONEAL; MALE; MICE; PROTO-ONCOGENE PROTEINS C-FOS;

EID: 84885669915     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2012.227     Document Type: Article

References (34)

1. National Institute for Health and Clinical Excellence. Type 2 diabetes: The management of type 2 diabetes. Clinical Guideline 2008; 66: 16.
2. Kendall DM, Riddle MC, Rosenstock J, Zhuang D, Kim DD, Fineman MS et al. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea. Diabetes Care 2005; 28: 1083-1091.
3. Geary N, Le Sauter J, Noh U. Glucagon acts in the liver to control spontaneous meal size in rats. Am J Physiol 1993; 264: R116-R122.
4. Le Sauter J, Noh U, Geary N. Hepatic PORtal infusion of glucagon antibodies increases spontaneous meal size in rats. Am J Physiol 1991; 261: R162-R165.
5. Geary N, Smith GP. Pancreatic glucagon and postprandial satiety in the rat. Physiol Behav 1982; 28: 313-322.
6. Schulman J, Carleton J, Whitney G, Whitehorn J. Effect of glucagon on food intake and body weight in man. J Appl Physiol 1957; 11: 419-421.
7. Holloway S, Stevenson J. Effect of glucagon on food intake and weight gain in the young rat. Can J Physiol Pharmacol 1964; 42: 867-869.
8. Langhans W, Zeiger U, Scharrer E, Geary N. Stimulation of feeding in rats by intraperitoneal injection of antibodies to glucagon. Science 1982; 218: 894-896.
9. Nair KS. Hyperglucagonemia increases resting metabolic rate in man during insulin deficiency. J Clin Endocrinol Metab 1987; 64: 896-901.
10. Calles-Escandon J. Insulin dissociates hepatic glucose cycling and glucagoninduced thermogenesis in man. Metabolism 1994; 43: 1000-1005.
11. Heppner KM, Habegger KM, Day J, Pfluger PT, Perez-Tilve D, Ward B et al. Glucagon regulation of energy metabolism. Physiol Behav 2010; 100: 545-548.
12. Abbott CR, Monteiro M, Small CJ, Sajedi A, Smith KL, Parkinson JR et al. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagalbrainstem-hypothalamic pathway. Brain Res 2005; 1044: 127-131.
13. Geary N, Smith GP. Selective hepatic vagotomy blocks pancreatic glucagon's satiety effect. Physiol Behav 1983; 31: 391-394.
14. Ritter S, Weatherford SC, Stone SL. Glucagon-induced inhibition of feeding is impaired by hepatic PORtal alloxan injection. Am J Physiol 1986; 250: R682-R690.
15. Weatherford SC, Ritter S. Lesion of vagal afferent terminals impairs glucagoninduced suppression of food intake. Physiol Behav 1988; 43: 645-650.
16. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 1996; 379: 69-72.
17. Neary NM, Small CJ, Druce MR, Park AJ, Ellis SM, Semjonous NM et al. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology 2005; 146: 5120-5127.
18. Franklin KBJ, Paxinos G. The Mouse Brain in Stereotaxic Coordinates. Third eds (Academic Press: San Diego, 2007.
19. Day JW, Ottaway N, Patterson JT, Gelfanov V, Smiley D, Gidda J et al. A new glucagon and GLP-1 co-agonist eliminates obesity in rodents. Nat Chem Biol 2009; 5: 749-757.
20. Pocai A, Carrington PE, Adams JR, Wright M, Eiermann G, Zhu L et al. Glucagonlike peptide 1/glucagon receptor dual agonism reverses obesity in mice. Diabetes 2009; 58: 2258-2266.
21. Barrera JG, D'Alessio DA, Drucker DJ, Woods SC, Seeley RJ. Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats. Diabetes 2009; 58: 2820-2827.
22. Baumgartner I, Pacheco-Lopez G, Ruttimann EB, Arnold M, Asarian L, Langhans W et al. Hepatic-PORtal vein infusions of GLP-1 reduce meal size and increase c-Fos expression in the NTS, AP, and CeA in rats. J Neuroendocrinol 2010; 22: 557-563.
23. Leslie RA, Gwyn DG, Hopkins DA. The central distribution of the cervical vagus nerve and gastric afferent and efferent projections in the rat. Brain Res Bull 1982; 8: 37-43.
24. Shapiro RE, Miselis RR. The central organization of the vagus nerve innervating the stomach of the rat. J Comp Neurol 1985; 238: 473-488.
25. Kobashi M, Adachi A. A direct hepatic osmoreceptive afferent projection from nucleus tractus solitarius to dorsal hypothalamus. Brain Res Bull 1988; 20: 487-492.
26. Hoosein NM, Gurd RS. Identification of glucagon receptors in rat brain. Proc Natl Acad Sci USA 1984; 81: 4368-4372.
27. Merchenthaler I, Lane M, Shughrue P. Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J Comp Neurol 1999; 403: 261-280.
28. Baraboi ED, St-Pierre DH, Shooner J, Timofeeva E, Richard D. Brain activation following peripheral administration of the GLP-1 receptor agonist exendin-4. Am J Physiol Regul Integr Comp Physiol 2011; 301: R1011-R1024.
29. Herbert H, Moga MM, Saper CB. Connections of the parabrachial nucleus with the nucleus of the solitary tract and the medullary reticular formation in the rat. J Comp Neurol 1990; 293: 540-580.
30. Norgren R, Leonard CM. Ascending central gustatory pathways. J Comp Neurol 1973; 150: 217-237.
31. Norgren R. Taste pathways to hypothalamus and amygdala. J Comp Neurol 1976; 166: 17-30.
32. Olson BR, Freilino M, Hoffman GE, Stricker EM, Sved AF, Verbalis JG. c-Fos expression in rat brain and brainstem nuclei in response to treatments that alter food intake and gastric motility. Mol Cell Neurosci 1993; 4: 93-106.
33. Geary N. Failure of pulsatile infusion to increase glucagon's satiating potency. Physiol Behav 1996 Apr; 59: 613-616.
34. Bloom SR, Daniel PM, Johnston DI, Ogawa O, Pratt OE. Release of glucagon, induced by stress. Q J Exp Physiol Cogn Med Sci 1973; 58: 99-108.